Clinical Trial Update: Study to Compare the Efficacy & Safety of Ursoplus Capsules vs. UDCA vs. Placebo Among Chronic Liver Disease Patients [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating Ursoplus capsules versus UDCA and placebo in chronic liver disease patients; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Disease

Drugs mentioned

• UDCA (ursodeoxycholic acid)
• Ursoplus capsules

Snippet

Sponsor: MinaPharm Pharmaceuticals | Conditions: Chronic Liver Disease | Phase 4 | Status: UNKNOWN